The global costs of schizophrenia.
Schizophrenia is a chronic disease associated with a significant and long-lasting health, social, and financial burden, not only for patients but also for families, other caregivers, and the wider society. Many national and local studies have sought to estimate the societal burden of the illness--or...
Egile Nagusiak: | Knapp, M, Mangalore, R, Simon, J |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2004
|
Antzeko izenburuak
-
The cost of schizophrenia in Japan
nork: Sado M, et al.
Argitaratua: (2013-05-01) -
The global prevalence of schizophrenia.
nork: Dinesh Bhugra
Argitaratua: (2005-05-01) -
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
nork: Correll Christoph U, et al.
Argitaratua: (2008-04-01) -
Costs and efficacy ofolanzapine and risperidone in schizophrenia
nork: Vittorio Mapelli
Argitaratua: (2007-06-01) -
The cost of relapse and the predictors of relapse in the treatment of schizophrenia
nork: Slade Eric P, et al.
Argitaratua: (2010-01-01)